Navigation Links
Alexza Announces Preliminary Results from its AZ-104 (Staccato(R) Loxapine) Phase 2b Trial in Patients with Migraine Headache
Date:9/14/2009

MOUNTAIN VIEW, Calif., Sept. 14 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced preliminary results from its 366 patient Phase 2b clinical trial of AZ-104 (Staccato(R) loxapine) in patients with migraine headache. Both AZ-104 dose groups trended towards statistical significance, but the study did not meet its primary endpoint, which was defined as pain-relief at the 2-hour time point, compared to placebo. There were no serious adverse events in the clinical trial, and AZ-104 was generally safe and well tolerated in this patient population.

"The failure to reach statistical significance on the primary endpoint is disappointing, as we were not able to reproduce the positive clinical findings from our AZ-104 Phase 2a proof-of-concept clinical trial," said James V. Cassella, PhD, Senior Vice President, Research and Development at Alexza. "Loxapine is a drug that had not been previously studied in migraine patients, except for our earlier proof-of-concept study. As part of our collaboration with Symphony Allegro, we initiated this migraine program in 2007 to investigate whether loxapine might be a viable product candidate for migraine, due to the scientific rationale that loxapine's primary mechanism of action (dopamine antagonism) has shown effectiveness in treating migraine."

"We continue to be impressed with Staccato's ability to safely and very accurately deliver a portfolio of drugs in a simple, one-breath, patient-controlled inhalation," said Thomas B. King, President and CEO of Alexza. "The uniqueness of our Staccato technology allows us to examine medicines for both known and new indications, and we will continue to do so in a patient setting. Not every clinical trial will necessarily have posit
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... present a corporate overview and update at the Piper Jaffray ... 2014, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time), ... York . A live audio webcast of ... of Arena,s website at www.arenapharm.com . A replay of ...
(Date:11/24/2014)...  Marta Rendon, MD, founder of the Rendon Center for ... FL and international key opinion leader in dermatology, was one of ... States to attend the international Aesthetic Experts Summit ... Here, at this gathering of over 600 physicians from 57 ... surgery experts from Asia and ...
(Date:11/24/2014)... 24, 2014  Surgical Theater, LLC, announced today that ... th opening of Europe,s ... "C. Besta." The SuRgical Planner (SRP) and the Surgical ... event for their 3D navigation and augmented reality capabilities ... , Professor and Chair, Department of Neurosurgery at Mount ...
Breaking Medicine Technology:Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 3
... China , June 30 /PRNewswire-Asia/ -- Simcere Pharmaceutical ... of branded generic and,innovative pharmaceuticals in China , today ... the year ended December 31, 2009 with the ... annual report can be accessed on,the Company,s website at ...
... CLEVELAND, Ohio , ... Simbionix USA Corporation, the world,s leading provider of,medical education ... industry, and USF Health, an organization dedicated to,creating a ... spectrum of,health, are proud to announce that together they ...
Cached Medicine Technology:Simcere Pharmaceutical Group Files Annual Report on Form 20-F 2Simcere Pharmaceutical Group Files Annual Report on Form 20-F 3Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation 2Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation 3Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation 4
(Date:11/26/2014)... Aurora, CO (PRWEB) November 26, 2014 For ... fast, the new LES MILLS BODYPUMP™ classes at ... be just the workout they've been looking for. The 45- ... with CU Anschutz Health and Wellness Center fitness club memberships. ... muscles. The workouts are fast-paced and are aimed at fast ...
(Date:11/26/2014)... 2014 Sonoran Vein and Endovascular ... the Distinguished Preceptorship Award from The American ... in the advancement of nurse practitioners. The Distinguished ... who had made a significant contribution toward increasing ... Association of Nurse Practitioners (AANP) is the largest ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Vultures have developed highly ... ingest when eating dead animals, researchers report. The ... on the faces and in the guts of 50 ... On average, the faces of the vultures had more ... in their guts, the study found. The findings ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Exposure to peanut protein ... allergy in infants with the skin condition eczema, a ... children in the United States are allergic to peanuts. ... food allergies, particularly peanut allergy, the researchers noted. ... to 15 months. The researchers examined the amount of ...
(Date:11/26/2014)... -- Parents need to take an active role in ... Parents must make sure sports-playing teens have the ... chair of the American Migraine Foundation and a professor ... in Scottsdale, Ariz. in an American Migraine Foundation, said ... involved with teens sports needs to have appropriate training. ...
Breaking Medicine News(10 mins):Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2
... -- The ability to remember the origin of memories isn,t ... ability refers not only to memories of past events but ... example, remembering not just meeting a particular person but the ... explained. They tested and monitored the brain activity of ...
... University of Toronto reveal that when it comes to white men, ... of black men, gays have a likability edge. In one ... and gay black and white males and rated their likeability on ... were not informed that some of the men pictured were gay. ...
... , FRIDAY, Sept. 2 (HealthDay News) -- A boy,s relationship ... way it changes can affect his behavior when he,s a ... pairs from low-income families in Pittsburgh who were followed from ... researchers assessed the level of conflict and warmth between the ...
... services of hospital-based radiology groups before allowing radiology departments ... according to an article in the September 2011 issue ... Radiology. Although imaging has become an increasingly ... and injury, hospital-based imaging is now often read by ...
... September 1, 2011 (BRONX, NY) In the largest ... week,s 9/11 Special Issue of The Lancet found ... Trade Center (WTC) disaster site were at least 19 percent ... the disaster as their non-exposed colleagues and up to 10 ...
... (HealthDay News) -- Microscopic brain lesions that are too small ... cause of many common age-related problems such as shaking hands, ... Researchers examined brain autopsies of 418 nuns and priests, average ... as part of an aging study. There were blockages in ...
Cached Medicine News:Health News:U of T study suggests sexual orientation unconsciously affects our impressions of others 2Health News:Close Bond With Mom Helps Keep Teen Boys Safe 2Health News:World Trade Center-exposed NYC firefighters face increased cancer risk 2Health News:World Trade Center-exposed NYC firefighters face increased cancer risk 3Health News:Old-Age Tremors May Be Caused by Brain Lesions 2
The IDS Gamma-B 25-Hydroxy Vitamin D kit is a conventional liquid phase radioimmunoassay intended for the quantitative determination of 25-hydroxy vitamin D (25-OHD) and other hydroxylated metabolite...
... This is the comprehensive, simple and ... has a compact, bench-top design, but ... previously only found in high-volume systems. ... cost-effective solution and can also be ...
A complete workstation for haemostasis , A compact and convenient analyser , A comprehensive system , An exellent reliability: the STAGO patented detection mode...
... a fully automated open random access ... immunological, latex based coagulation tests. The ... racks as sample carrier offers 220 ... to 70 reagents on-board with the ...
Medicine Products: